Literature DB >> 16359934

Quantitation of salbutamol in human urine by liquid chromatography-electrospray ionization mass spectrometry.

Jianli Zhang1, Youxuan Xu, Xin Di, Moutian Wu.   

Abstract

A sensitive and specific liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) is described for quantitation of salbutamol in human urine using nadolol as the internal standard (I.S.). Urine samples were hydrolyzed with beta-glucuronidase followed by a solid-phase extraction procedure using Bond Elut-Certify cartridges. The HPLC column was an Agilent Zorbax SB-C(18) column. A mixture of 0.01 M ammonium formate buffer (pH 3.5)-acetonitrile (85:15, v/v) was used as the mobile phase. Analytes were quantitated using positive electrospray ionization in a quadrupole spectrometer. Selected ion monitoring (SIM) mode was used to monitor m/z 166 for salbutamol and m/z 310 for I.S. Good linearity was obtained in the range of 10.0-2000.0 ng/ml. The limit of quantification was 10.0 ng/ml. The intra- and inter-run precision, calculated from quality control (QC) samples was less than 7.3%. The accuracy as determined from QC samples was within +/-2.6%. The method was applied for determining excretion curves of salbutamol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359934     DOI: 10.1016/j.jchromb.2005.11.041

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Development of a Microemulsion High Performance Liquid Chromatography (MELC) Method for Determination of Salbutamol in Metered-Dose Inhalers (MDIS).

Authors:  Ms Althanyan; Bj Clark; J Hanaee; Kh Assi
Journal:  Bioimpacts       Date:  2013-02-16

2.  Superhydrophobic Surface for Enhancing the Bioavailability of Salbutamol Sulfate from Cross-Linked Microspheres: Formulation, Characterization, and in vivo Evaluation.

Authors:  Dalia Gaber; Siham Abdoun; Ameerah Alfuraihy; Bushra Altasan; Amal Alsubaiyel
Journal:  Drug Des Devel Ther       Date:  2021-07-02       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.